Zogenix_July_2018_821_29821
Loading viewer...
report
Format: PDF report
This report presents the top-line results of Zogenix's Phase 3 Study 1504, highlighting the efficacy of ZX008 for treating seizures in Dravet syndrome.
Loading viewer...
report
Format: PDF report
This report presents the top-line results of Zogenix's Phase 3 Study 1504, highlighting the efficacy of ZX008 for treating seizures in Dravet syndrome.
Zogenix Q4 2016 Financial Results Earnings Presentation
earningsearnings
20 Pages
report
AL HAMRA TOWER
report
Bristol Myers Squibb
report
Cahaba GBA
report
Gilead Biosciences
